ECB: Financing conditions are relaxing, ECB: Financing conditions are relaxing. However, because monetary policy is still restrictive and past interest rate hikes are still being transmitted to the credit stock, financing conditions are still tightening. Inflation prospect, core inflation and its transmission will determine the interest rate path.European Central Bank: It is estimated that the GDP growth rate will be 0.7% in 2024, 1.1% in 2025, 1.4% in 2026 and 1.3% in 2027. (It is expected to be 0.8%, 1.3% and 1.5% respectively in September) It is estimated that the core inflation rate will be 2.9% in 2024, 2.3% in 2025 and 1.9% in 2026. (It is expected to be 2.8%, 2.3% and 2.0% respectively in September) It is estimated that the core inflation rate will be 1.9% in 2027.The United States ITC issued a 337-part final ruling on the wireless front-end module and its downstream equipment. According to the China Trade Relief Information Network, on December 10, 2024, the United States International Trade Commission (ITC) issued a notice saying that it made a 337-part final ruling on a specific wireless front-end module and its downstream equipment: the preliminary ruling (No.13) made by the administrative judge in this case on November 8, 2024 will not be reviewed, that is, based on the withdrawal of the applicant, Kangxi Communication Technology (Shanghai) Co., Ltd. and Ruijie Network Co., Ltd. are listed as defendants.
Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).Indian government sources: negotiations on a free trade agreement between India and Britain will begin at the end of January next year.During the "slimming" of the brokerage business department, more than 100 companies were cancelled during the year, and the competition turned to differentiated services. The brokerage business of brokerage companies is welcoming a new round of changes. In the past few days, a number of brokers have announced the cancellation of their relevant business departments. According to the reporter's incomplete statistics, in the past two weeks, many brokers such as Nanjing Securities, Guosen Securities and Pacific Securities announced that they would "streamline" their business departments. Looking at it for a long time, more than 35 brokers have issued announcements during the year, "downsizing" hundreds of business departments. Insiders pointed out that the traditional offline outlet business development model has increasingly shown drawbacks and high cost pressure; At the same time, more and more customers rely on online transactions and mobile terminal transactions, so it is imperative to "streamline" the business department to reduce costs and increase efficiency. Future competition depends more on differentiated financial management and trading services. (Shell Finance)
The United States ITC issued a 337-part final ruling on the wireless front-end module and its downstream equipment. According to the China Trade Relief Information Network, on December 10, 2024, the United States International Trade Commission (ITC) issued a notice saying that it made a 337-part final ruling on a specific wireless front-end module and its downstream equipment: the preliminary ruling (No.13) made by the administrative judge in this case on November 8, 2024 will not be reviewed, that is, based on the withdrawal of the applicant, Kangxi Communication Technology (Shanghai) Co., Ltd. and Ruijie Network Co., Ltd. are listed as defendants.European Central Bank: It is estimated that the GDP growth rate will be 0.7% in 2024, 1.1% in 2025, 1.4% in 2026 and 1.3% in 2027. (It is expected to be 0.8%, 1.3% and 1.5% respectively in September) It is estimated that the core inflation rate will be 2.9% in 2024, 2.3% in 2025 and 1.9% in 2026. (It is expected to be 2.8%, 2.3% and 2.0% respectively in September) It is estimated that the core inflation rate will be 1.9% in 2027.Real estate stocks are active again and again. Huayuan Real Estate and Qixia Construction both have daily limit, while Huayuan Real Estate, Qixia Construction, Xinhualian and Xinhuangpu have daily limit, while Suzhou Gaoxin, China Wuyi and Shahe shares have followed suit.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14